M&A Deal Summary

Rosen s Diversified Acquires Collagen Solutions

On October 20, 2020, Rosen s Diversified acquired life science company Collagen Solutions from Calculus Capital for 32M GBP

Acquisition Highlights
  • This is Rosen s Diversified’s 1st transaction in the Life Science sector.
  • This is Rosen s Diversified’s 0th largest (disclosed) transaction.
  • This is Rosen s Diversified’s 1st transaction in the United Kingdom.
Investment Fate
  • Collagen Solutions was divested to a consortium of strategic buyers in 2024.

M&A Deal Summary
Date 2020-10-20
Target Collagen Solutions
Sector Life Science
Buyer(s) Rosen s Diversified
Sellers(s) Calculus Capital
Deal Type Add-on Acquisition
Deal Value 32M GBP
Advisor(s) Shepherd and Wedderburn (Legal)

Target

Collagen Solutions

London, United Kingdom
Collagen Solutions is a contract developer and manufacturer of regenerative medical devices using collagen and tissue-based biomaterials, as well as a supplier of these materials. These products are used in a wide variety of applications including orthopedics, cardiovascular, dental, wound healing and neurology. Collagen Solutions was founded in 2012 and is based in London, United Kingdom.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Rosen s Diversified

Fairmont, Minnesota, United States
Category Company
Founded 1946
Sector Diversified
DESCRIPTION

Rosen's Diversified, Inc. sells a broad range of food, agricultural and scientific products into more than 30 countries, across five continents. Rosen's Diversified was founded in 1946 and is based in Fairmont, Minnesota.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (United Kingdom) 1 of 1
Year (2020) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-10-07 Collagen Solutions

London, United Kingdom

Collagen Solutions is a contract developer and manufacturer of regenerative medical devices using collagen and tissue-based biomaterials, as well as a supplier of these materials. These products are used in a wide variety of applications including orthopedics, cardiovascular, dental, wound healing and neurology. Collagen Solutions was founded in 2012 and is based in London, United Kingdom.

Sell -

Seller(S) 1

SELLER

Calculus Capital

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1999
Size Small
Type Sector Agnostic
DESCRIPTION

Calculus Capital is a UK-based investment group focused on fast-growth companies. Calculus Capital is sector agnostic and looks to commit £2 to £5 million per investment. Calculus Capital is based in London.

DEAL STATS #
Overall 7 of 15
Sector (Life Science) 4 of 5
Type (Add-on Acquisition) 4 of 11
Country (United Kingdom) 7 of 14
Year (2020) 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-09-28 genedrive

Manchester, United Kingdom

genedrive is a commercial stage personalised medicine and biotechnology company developing innovative diagnostics and biomarkers alongside providing contract research services to drug development companies. genedrive was founded in 2000 and is based in Manchester, the United Kingdom.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-29 Chop’d

London, United Kingdom

Chop’d is a operater of salad bar restaurant chains with 14+ sites. Chop’d was founded in 2002 and is based in London, United Kingdom.

Sell -
Mergr

Product

Company

Legal